Streetbeat News

Products Services

BDX

Becton, Dickinson (BDX) has started the AGILITY clinical study to evaluate the safety and effectiveness of its BD Vascular Covered Stent for Peripheral Arterial Disease. The study will involve 315 patients across the US, Europe, Australia, and New Zealand, with follow-ups ranging from one month to 36 months.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 11:52 am

SWTX

SpringWorks Therapeutics has begun a rolling submission of a New Drug Application to the FDA for Mirdametinib, aimed at treating Neurofibromatosis Type 1-associated Plexiform Neurofibromas in both pediatric and adult patients. The submission process is expected to be completed by the second quarter of 2024.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 11:37 am

IOVA

The FDA has lifted a partial clinical hold on Iovance Biotherapeutics' IOV-LUN-202 trial, which is investigating LN-145 TIL cell therapy for non-small cell lung cancer. This development could potentially accelerate the trial's progress and bring the therapy closer to market.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 11:35 am

NVDA

China is offering 'computing vouchers' worth $140,000 to $280,000 to AI startups to mitigate the impact of U.S. chip restrictions. This initiative aims to support the training and operation of large language models (LLMs) amid challenges such as contract cancellations by cloud computing services due to U.S. controls. Nvidia (NASDAQ:NVDA) chips are being repurposed for AI tasks due to these restrictions. Additionally, China plans to introduce a subsidy program for AI groups using domestic chips and is developing an alternative to Big Tech's data centers.

Portfolio Pulse from Benzinga Neuro

March 04, 2024 | 11:15 am

DOGEUSD

A cryptocurrency analyst, 'Credible Crypto', turned a $10,000 Dogecoin (DOGE) trade into $100,000 in 48 hours using a 50x leverage amidst a market-wide bullish trend. The trade was based on technical analysis and a prediction of DOGE breaking out from a stable price phase. Dogecoin's price rose over 70% in the past week, with a notable increase in accumulations by large holders.

Portfolio Pulse from Mehab Qureshi

March 04, 2024 | 11:13 am

BONKUSD

DOGEUSD

FLOKIUSD

SHIBUSD

Floki (CRYPTO: FLOKI) surged 326% in a week after its community voted to burn 2% of its total tokens, removing 190 billion tokens worth $27 million from circulation. This move aims to enhance network security and is part of broader excitement in meme-themed cryptocurrencies. Other meme tokens like Dogecoin, Shiba Inu, and Bonk also saw significant price increases. Floki's staking program and FlokiFi Locker protocol contribute to its burning mechanism. Analyst Inmortal predicts a bullish trend for Floki, comparing it to Pepe's recent performance.

Portfolio Pulse from Mehab Qureshi

March 04, 2024 | 10:59 am

GSM

LONGi, a leading solar technology company, and Ferroglobe PLC, a top producer of Silicon Metal and Ferroalloys, have entered into a long-term supply agreement starting January 1, 2024. Ferroglobe will supply high-quality quartzite and metallurgical grade silicon to LONGi, enhancing their partnership and collaboration.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 10:49 am

LEAS

RWOD

ANEW Medical, Inc. (OTCPK: LEAS), a US-based biotech company, has been granted a patent in China for its Klotho protein and gene delivery systems for treating neurodegenerative diseases. Additionally, ANEW announced a proposed merger with SPAC Redwoods (NASDAQ: RWOD) in May 2023.

Portfolio Pulse from Charles Gross

March 04, 2024 | 10:15 am

AZN

The European Medicines Agency has validated two marketing authorization applications for AstraZeneca and Daiichi Sankyo's Datopotamab Deruxtecan (Dato-DXD) for treating two types of cancer: NSCLC and HR-positive, HER2-negative breast cancer.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 10:13 am

QH

Quhuo Limited (NASDAQ: QH), a leading gig economy platform in China, has expanded its homestay business through its Chengtu Home division by launching 'Chengtu Rural Residence,' a new brand focusing on rural homestays. The initiative starts in Wuqing District, Tianjin City, and Beidaihe Village, Qinhuangdao, covering nearly 40 homes.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 10:07 am